ArticleBiosensors2026
A Comparison of Cost-Effective Sensors for a Fluorescence-Based Detection System Used in Biodiagnostic Devices.
Article in Biosensors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Cost-effective, fluorescence-based biodiagnostic devices have the potential to expand point-of-care (POC) testing in resource-limited settings, thereby creating new opportunities for accessible and decentralised diagnostics. The objective of this study is to investigate the performance of a newly designed and simplified system that uses several cost-effective sensors for use in a fluorescence-based biodiagnostic setup. A collecting setup that includes an elliptical mirror to focus emitted fluorescence onto the semiconductor sensors was designed for an intensity-based readout. The readout was realised by various photodiodes, photoresistors, phototransistors and one multi-pixel photon counter (MPPC). Over a range of fluorophore concentrations using serial dilutions of Rhodamine B (RhB), the limit of detection (LOD) and limit of quantification (LOQ) at system level were evaluated. With the exception of the photodiodes, the system demonstrated promising performance with all sensors. The system using the photoresistors achieved the lowest LOD but showed limited repeatability, while the system using the MPPC and phototransistors exhibited high repeatability. A proof-of-concept demonstrated the feasibility of a photoresistor-based configuration by using a sandwich immunoassay for the detection of the antigen Human Epidermal growth factor Receptor 2 (HER2) (100 nM). While this study has not yet encompassed the full spectrum of clinically relevant concentrations, it has yielded valuable insights to enable further enhancements, without the necessity for highly specialised or costly equipment. The limitations and necessary improvements for further developments are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.